Azenta (AZTA) Stock: Buy, Sell, or Hold?
AZTA - Azenta, Inc.
$30.85
0.67 (2.22%)
▲
5d:
-1.06%
30d:
-7.99%
90d:
+37.36%
HOLD
MODERATE Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Get Alerted When AZTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AZTA trades at premium valuation expecting 13.2% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: AZTA trades at premium valuation expecting 13.2% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$28.60
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$17.76
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AZTA is currently trading at $30.85, which is considered oversold relative to its 30-day fair value range of $31.03 to $34.52. From a valuation perspective, the stock is trading at a premium (Forward PE: 52.5) compared to its historical average (36.2). At these levels, the market is pricing in 13.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, AZTA is in a strong uptrend. Immediate support is located at $29.64, while resistance sits at $33.76.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $35.25 (+14.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AZTA is in a strong uptrend. Immediate support is located at $29.64, while resistance sits at $33.76.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $35.25 (+14.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$31.03 -
$34.52
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
81.5%
Protect Your Profits
Holding AZTA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($35.25)
- NEUTRAL: PE elevated vs history but 13.2% growth expectation is conservative given 8778% recent growth
- NEUTRAL: Bottoming setup forming (40/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$31.03 -
$34.52
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$2.92
(9.5%)
Support & Resistance Levels
Support Level
$29.64
Resistance Level
$33.76
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
52.51
Wall Street Target
$35.25
(+14.3%)
Revenue Growth (YoY)
12.0%
Earnings Growth (YoY)
8777.8%
Profit Margin
-20.0%
Valuation Premium vs History
+13.2% premium
PE vs Historical
52.5 vs 36.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+13.2%
(market-implied from PE analysis)
1-Year Target
$34.92
(+13%)
2-Year Target
$39.53
(+28%)
3-Year Target
$44.75
(+45%)
3-Yr Target (if PE normalizes)
(PE: 53→36)
PE COMPRESSION
$30.85
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 52.5, Growth: 56.7%)
$104.12
(+238%)
Base:
(SPY PE: 20.2, Growth: 56.7%)
$39.99
(+30%)
Bear:
(PE: 17.1, Growth: 56.7%)
$33.99
(+10%)
Share & Embed Analysis
Last updated: September 13, 2026 12:02 AM ET
Data refreshes hourly during market hours. Next update: 1:02 AM
Data refreshes hourly during market hours. Next update: 1:02 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AZTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 53 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$85 | 35 SELL |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$405 | 63 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$188 | 45 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$246 | 41 HOLD |
Advanced AZTA Option Strategies
Professional options setups generated by AI based on today's AZTA price and gamma walls.
